SCAI Scientific Sessions 2025 will take place May 1 to 3, at the Walter E. Washington Convention Center in Washington, DC.
Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE):
- “Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial”
- “The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation of the Neuroguard IEP® 3-in-1 Carotid Stent System with Integrated Embolic Protection. Stent Durability and Patency at 2 years”
- “A Prospective Study of the Next Generation AVENTUS Thrombectomy System: Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism”
- “Incidence and Gender-Based Comparison of Prosthesis-Patient Mismatch (PPM) in patients undergoing transcatheter aortic valve implantation (TAVI)”
- “Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population”
For more information on the conference or to register to attend, please visit https://scai.org/scai-2025-scientific-sessions
February 18, 2025 
